From Seattle Biotech Needs More Bars, Less University Red Tape, and the Same Daring Attitude, & Other Highlights from Seattle Life Sciences 2029:

ARCH Venture Partners managing director and Allozyne chairman Steve Gillis
ARCH Venture Partners managing director and Allozyne chairman Steve Gillis

Steve Gillis is a managing director of Arch Venture Partners.